ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,761.00
0.77%
S&P ASX All Technology
3,066.90
-0.26%
Brent Oil
80.61
-0.24%
US Dollar vs AUD
1.50072
0.14%
Bitcoin
69,648.00
2.80%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Pharmadrug Inc (PK) (LMLLF)

  7. Pharmadrug Inc (PK) (LMLLF) News

LMLLF

Pharmadrug (PK) (LMLLF)

Pharmadrug Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:LMLLF
DateTimeSourceHeadlineSymbolCompany
24/05/202402:34AllPennyStocks.comSpecialty Pharma Company Moving Higher After Signing LOI for Pharmaceutical-Grade CocaineUSOTC:LMLLFPharmadrug Inc (PK)
30/09/202100:20AllPennyStocks.comPharma Stock Bid Up For Second Day!USOTC:LMLLFPharmadrug Inc (PK)
20/04/202123:41InvestorsHub NewsWirePHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASESUSOTC:LMLLFPharmadrug Inc (PK)
16/03/202123:10InvestorsHub NewsWirePHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCHUSOTC:LMLLFPharmadrug Inc (PK)
26/02/202100:13InvestorsHub NewsWirePHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGYUSOTC:LMLLFPharmadrug Inc (PK)
12/02/202100:18InvestorsHub NewsWirePHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKEUSOTC:LMLLFPharmadrug Inc (PK)
09/02/202100:00InvestorsHub NewsWirePHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...ContUSOTC:LMLLFPharmadrug Inc (PK)
05/02/202100:58InvestorsHub NewsWirePHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONSUSOTC:LMLLFPharmadrug Inc (PK)
03/02/202100:48InvestorsHub NewsWirePHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.USOTC:LMLLFPharmadrug Inc (PK)
13/01/202100:40InvestorsHub NewsWirePHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INCUSOTC:LMLLFPharmadrug Inc (PK)
 Showing the most relevant articles for your search:USOTC:LMLLF

Your Recent History

ASX
XJO
S&P ASX 200
ASX
XAO
Australian SE All Ordina...
NYSE
KO
Coca Cola
ASX
WOW
Woolworths
COIN
BTCUSD
Bitcoin
ASX
XMM
S&P ASX 300 Metals and M...
NASDAQ
MSFT
Microsoft
ASX
XTO
S&P ASX 100
PM
XAUUSD
Gold vs US Dollar
ASX
CSL
CSL
ASX
ORG
Origin Energy
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
ASX
AMP
AMP
NASDAQ
AMZN
Amazon.com
FX
AUDUSD
AUD vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved